US00547W2089 - ADMP - A1XA2F (XNAS)
ADAMIS PHARMACEUTICALS CORP Aktie
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | -6,22 % | -98,81 % |
Firmenprofil zu ADAMIS PHARMACEUTICALS CORP Aktie
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the treatment of asthma; and naloxone injection for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, and injectables; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.
Unternehmensdaten zur ADAMIS PHARMACEUTICALS CORP Aktie
Name ADAMIS PHARMACEUTICALS CORP
Firma Adamis Pharmaceuticals Corporation
Symbol ADMP
Heimatbörse
NASDAQ
WKN A1XA2F
ISIN US00547W2089
Wertpapierart Aktie
Sektor Healthcare
Branche Drug Manufacturers - Specialty & Generic
CEO Dr. Ebrahim Versi M.D., Ph.D.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,0 T
Adresse 11682 El Camino Real, 92130 San Diego
IPO Datum 1995-08-14
Aktien Kennungs-Wechsel
Datum | Von | Zu |
---|---|---|
03.04.2009 | CLGY | ADMP |
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | ADMP |
Weitere Aktien
Investoren die ADAMIS PHARMACEUTICALS CORP halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024